Is fibroblast growth factor 23 a new cardiovascular risk marker in gestational diabetes?

OBJECTIVE: This study was designed to compare the serum levels of fibroblast growth factor 23 (FGF23) among patients with gestational diabetes mellitus (GDM) and healthy pregnant women, and to evaluate the association between hormonal and metabolic parameters. SUBJECTS AND METHODS: A total of 82 pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kizilgul, Muhammed, Kan, Seyfullah, Beysel, Selvihan, Apaydin, Mahmut, Ozcelik, Ozgur, Caliskan, Mustafa, Ozbek, Mustafa, Ozdemir, Seyda, Cakal, Erman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522065/
https://www.ncbi.nlm.nih.gov/pubmed/28977159
http://dx.doi.org/10.1590/2359-3997000000287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522065/
https://www.ncbi.nlm.nih.gov/pubmed/28977159
http://dx.doi.org/10.1590/2359-3997000000287

Ejemplares similares